Extraskeletal myxoid chondrosarcoma: A review of 23 patients treated at a single referral center with long-term follow-up

Koichi Ogura, Tomohiro Fujiwara, Yasuo Beppu, Hirokazu Chuman, Akihiko Yoshida, Hirotaka Kawano, Akira Kawai

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background :Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma.Although it has been regarded as a low-grade sarcoma unassociated with tumorrelated death, a recent study has suggested an insidious nature with a high propensity for relapse during a long disease course. The aim of this study was to clarify the long-term clinical features of EMC treated at a single referral center using state-of-the-art techniques. Methods A retrospective review of 23 consecutive patients (10 males, 13 females; mean age 58 years) treated between 1979 and 2008 (mean follow-up; 109 months) was performed. Results :Surgery for the primary tumor was performed in 22 patients, and 7 cases recurred locally due to inadequate resection. Eleven patients had metastatic disease, either at diagnosis (3) or developing later (8). The 5/10-year overall survival rates were 91/84 %, and the 5/10-year local recurrence-free and metastasis-free survival rates for patients with localized disease were 89/62 and 89/61 %, respectively. Larger tumor size ([10 cm) and metastases at diagnosis were significant negative prognostic factors. Four.

Original languageEnglish
Pages (from-to)1379-1386
Number of pages8
JournalArchives of Orthopaedic and Trauma Surgery
Volume132
Issue number10
DOIs
Publication statusPublished - Oct 2012
Externally publishedYes

Fingerprint

Referral and Consultation
Sarcoma
Survival Rate
Neoplasm Metastasis
Recurrence
Neoplasms
Extraskeletal Myxoid Chondrosarcoma

Keywords

  • Chemotherapy
  • Extraskeletal myxoid chondrosarcoma
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Extraskeletal myxoid chondrosarcoma : A review of 23 patients treated at a single referral center with long-term follow-up. / Ogura, Koichi; Fujiwara, Tomohiro; Beppu, Yasuo; Chuman, Hirokazu; Yoshida, Akihiko; Kawano, Hirotaka; Kawai, Akira.

In: Archives of Orthopaedic and Trauma Surgery, Vol. 132, No. 10, 10.2012, p. 1379-1386.

Research output: Contribution to journalArticle

Ogura, Koichi ; Fujiwara, Tomohiro ; Beppu, Yasuo ; Chuman, Hirokazu ; Yoshida, Akihiko ; Kawano, Hirotaka ; Kawai, Akira. / Extraskeletal myxoid chondrosarcoma : A review of 23 patients treated at a single referral center with long-term follow-up. In: Archives of Orthopaedic and Trauma Surgery. 2012 ; Vol. 132, No. 10. pp. 1379-1386.
@article{93dac5173c904928849d3c877ef2dcd1,
title = "Extraskeletal myxoid chondrosarcoma: A review of 23 patients treated at a single referral center with long-term follow-up",
abstract = "Background :Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma.Although it has been regarded as a low-grade sarcoma unassociated with tumorrelated death, a recent study has suggested an insidious nature with a high propensity for relapse during a long disease course. The aim of this study was to clarify the long-term clinical features of EMC treated at a single referral center using state-of-the-art techniques. Methods A retrospective review of 23 consecutive patients (10 males, 13 females; mean age 58 years) treated between 1979 and 2008 (mean follow-up; 109 months) was performed. Results :Surgery for the primary tumor was performed in 22 patients, and 7 cases recurred locally due to inadequate resection. Eleven patients had metastatic disease, either at diagnosis (3) or developing later (8). The 5/10-year overall survival rates were 91/84 {\%}, and the 5/10-year local recurrence-free and metastasis-free survival rates for patients with localized disease were 89/62 and 89/61 {\%}, respectively. Larger tumor size ([10 cm) and metastases at diagnosis were significant negative prognostic factors. Four.",
keywords = "Chemotherapy, Extraskeletal myxoid chondrosarcoma, Radiotherapy, Surgery",
author = "Koichi Ogura and Tomohiro Fujiwara and Yasuo Beppu and Hirokazu Chuman and Akihiko Yoshida and Hirotaka Kawano and Akira Kawai",
year = "2012",
month = "10",
doi = "10.1007/s00402-012-1557-9",
language = "English",
volume = "132",
pages = "1379--1386",
journal = "Archiv fur orthopadische und Unfall-Chirurgie",
issn = "0003-9330",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Extraskeletal myxoid chondrosarcoma

T2 - A review of 23 patients treated at a single referral center with long-term follow-up

AU - Ogura, Koichi

AU - Fujiwara, Tomohiro

AU - Beppu, Yasuo

AU - Chuman, Hirokazu

AU - Yoshida, Akihiko

AU - Kawano, Hirotaka

AU - Kawai, Akira

PY - 2012/10

Y1 - 2012/10

N2 - Background :Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma.Although it has been regarded as a low-grade sarcoma unassociated with tumorrelated death, a recent study has suggested an insidious nature with a high propensity for relapse during a long disease course. The aim of this study was to clarify the long-term clinical features of EMC treated at a single referral center using state-of-the-art techniques. Methods A retrospective review of 23 consecutive patients (10 males, 13 females; mean age 58 years) treated between 1979 and 2008 (mean follow-up; 109 months) was performed. Results :Surgery for the primary tumor was performed in 22 patients, and 7 cases recurred locally due to inadequate resection. Eleven patients had metastatic disease, either at diagnosis (3) or developing later (8). The 5/10-year overall survival rates were 91/84 %, and the 5/10-year local recurrence-free and metastasis-free survival rates for patients with localized disease were 89/62 and 89/61 %, respectively. Larger tumor size ([10 cm) and metastases at diagnosis were significant negative prognostic factors. Four.

AB - Background :Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma.Although it has been regarded as a low-grade sarcoma unassociated with tumorrelated death, a recent study has suggested an insidious nature with a high propensity for relapse during a long disease course. The aim of this study was to clarify the long-term clinical features of EMC treated at a single referral center using state-of-the-art techniques. Methods A retrospective review of 23 consecutive patients (10 males, 13 females; mean age 58 years) treated between 1979 and 2008 (mean follow-up; 109 months) was performed. Results :Surgery for the primary tumor was performed in 22 patients, and 7 cases recurred locally due to inadequate resection. Eleven patients had metastatic disease, either at diagnosis (3) or developing later (8). The 5/10-year overall survival rates were 91/84 %, and the 5/10-year local recurrence-free and metastasis-free survival rates for patients with localized disease were 89/62 and 89/61 %, respectively. Larger tumor size ([10 cm) and metastases at diagnosis were significant negative prognostic factors. Four.

KW - Chemotherapy

KW - Extraskeletal myxoid chondrosarcoma

KW - Radiotherapy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84866984004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866984004&partnerID=8YFLogxK

U2 - 10.1007/s00402-012-1557-9

DO - 10.1007/s00402-012-1557-9

M3 - Article

C2 - 22678528

AN - SCOPUS:84866984004

VL - 132

SP - 1379

EP - 1386

JO - Archiv fur orthopadische und Unfall-Chirurgie

JF - Archiv fur orthopadische und Unfall-Chirurgie

SN - 0003-9330

IS - 10

ER -